Clinical trials
Radiculopathy Sacral clinical trials
Below are recruiting radiculopathy sacral clinical trials, each written for real people, not researchers. We’re tracking 2 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06421558Recruiting
Electrical stimulation for lower back nerve pain
This study tests whether a mild electrical stimulation applied to the lower back can help relieve pain from a pinched nerve. It involves weekly sessions for 6 weeks.
Escondido, CaliforniaAges 18 years+ - NCT06143813Recruiting
Precision treatment for lumbar nerve pain with targeted block
This trial tests if a targeted nerve root injection can improve outcomes for people with persistent leg pain from a compressed nerve in the lower back, with the goal of tailoring surgery more precisely.
Aarhus CAges 18 years+
Hear when a new Radiculopathy Sacral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for radiculopathy sacral?
- Yes. Clin2 currently lists 2 recruiting radiculopathy sacral studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a radiculopathy sacral trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a radiculopathy sacral trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.